WallStreetZenWallStreetZen

NYSEMKT: ARMP
Armata Pharmaceuticals Inc Stock Ownership - Who owns Armata Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Armata Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Deborah BirxChief Executive Officer2025-03-146,061$1.95
$11.82kSell
Pierre KymeChief Business Officer2025-03-141,027$1.95
$2.00kSell
Deborah BirxChief Executive Officer2024-07-1022,925$2.68
$61.44kSell

1 of 1

ARMP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARMP insiders and whales buy or sell their stock.

ARMP Shareholders

What type of owners hold Armata Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Innoviva Inc69.29%25,076,769$54.42MInsider
Randal J. Kirk61.25%22,169,127$48.11MInsider
Biogen Inc38.51%13,939,158$30.25MInsider
Elan Corp PLC32.12%11,626,282$25.23MInsider
Austin W. Greenhouse David M. Marxe6.51%2,355,475$5.11MInsider
Delta Dental Of Wisconsin Inc5.82%2,107,675$4.57MInsider
Louis P. Lacasse4.01%1,450,185$3.15MInsider
Delta Dental Plan Of Michigan Inc3.50%1,265,802$2.75MInsider
Jeremy Curnock Cook1.14%411,435$892.81kInsider
Michael S. Perry1.14%411,335$892.60kInsider

1 of 3

ARMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARMP0.89%99.11%Net Selling
ONCY1.58%0.00%
PLRX68.78%31.22%Net Selling
EPIX71.37%11.07%Net Selling
DOMH5.40%60.96%
View Top Biotech Stocks

Armata Pharmaceuticals Stock Ownership FAQ

Who owns Armata Pharmaceuticals?

Armata Pharmaceuticals (NYSEMKT: ARMP) is owned by 2.05% institutional shareholders, 226.73% Armata Pharmaceuticals insiders, and 0.00% retail investors. Innoviva Inc is the largest individual Armata Pharmaceuticals shareholder, owning 25.08M shares representing 69.29% of the company. Innoviva Inc's Armata Pharmaceuticals shares are currently valued at $54.42M.

If you're new to stock investing, here's how to buy Armata Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.